Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pfizer (PFE)
NYSE:PFE
Pfizer (PFE) Stock Price & Analysis
28,229 Followers
PFE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$24.82 - $38.23
Previous Close$28.64
Volume26.11M
Average Volume (3M)42.51M
Market Cap
$162.29B
Enterprise Value$220.18B
Total Cash (Recent Filing)$11.93B
Total Debt (Recent Filing)$69.54B
Price to Earnings (P/E)-471.8
Beta0.53
Next Earnings
Jul 30, 2024EPS Estimate
$0.45Last Dividend Ex-Date
May 09, 2024Dividend Yield5.76%
Share Statistics
EPS (TTM)-0.06
Shares Outstanding5,666,592,898
10 Day Avg. Volume40,552,721
30 Day Avg. Volume42,509,731
Standard Deviation0.08
R-Squared0.18
Alpha-0.00721
Financial Highlights & Ratios
Price to Book (P/B)-4.11
Price to Sales (P/S)10.91
Price to Cash Flow (P/CF)37.60
P/FCF Ratio37.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.00
Enterprise Value/Gross Profit6.56
Enterprise Value/Ebitda39.42
Forecast
1Y Price Target
$31.36Price Target Upside9.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering17
Pfizer News
Bulls Say, Bears Say
Bulls Say
Financial PerformancePfizer's first quarter results exceeded expectations with higher than anticipated revenue and earnings, showing strong financial performance.
Guidance And ProfitabilityThe company has raised its earnings guidance for the fiscal year, indicating confidence in its future profitability.
Strategic DirectionRenewed focus on key therapeutic areas like oncology and RSV, combined with cautious optimism about recent and near-term product launches, suggests Pfizer is poised for growth.
Bears Say
Drug Development ChallengesPfizer's withdrawal of the Phase 3 study for BID danu due to high gastrointestinal side effects and dropout rates indicates potential setbacks in its drug development pipeline.
Financial GuidancePfizer's modest raise in 2024 EPS guidance amidst a strong quarter raises questions about its ability to meet organic revenue targets.
Product PerformanceSales of key products like Nurtec, Prevnar, and Ibrance may fall short of expectations, potentially impacting overall financial performance.
---
Ownership Overview
0.26% Insiders
21.74% Mutual Funds
32.02% Other Institutional Investors
45.98% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PFE FAQ
What was Pfizer’s price range in the past 12 months?
Pfizer lowest stock price was $24.82 and its highest was $38.23 in the past 12 months.
What is Pfizer’s market cap?
Currently, no data Available
When is Pfizer’s upcoming earnings report date?
Pfizer’s upcoming earnings report date is Jul 30, 2024 which is in 72 days.
How were Pfizer’s earnings last quarter?
Pfizer released its earnings results on May 01, 2024. The company reported $0.82 earnings per share for the quarter, beating the consensus estimate of $0.516 by $0.304.
Is Pfizer overvalued?
According to Wall Street analysts Pfizer’s price is currently Undervalued.
Does Pfizer pay dividends?
Pfizer pays a Quarterly dividend of $0.42 which represents an annual dividend yield of 5.76%. See more information on Pfizer dividends here
What is Pfizer’s EPS estimate?
Pfizer’s EPS estimate is $0.45.
How many shares outstanding does Pfizer have?
Pfizer has 5,666,593,000 shares outstanding.
What happened to Pfizer’s price movement after its last earnings report?
Pfizer reported an EPS of $0.82 in its last earnings report, beating expectations of $0.516. Following the earnings report the stock price went up 6.101%.
Which hedge fund is a major shareholder of Pfizer?
Among the largest hedge funds holding Pfizer’s share is Diamond Hill Capital Management Inc. It holds Pfizer’s shares valued at 340M.
---
Pfizer Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$31.36 (9.50% Upside)
$31.36 (9.50% Upside)
Blogger Sentiment
Bullish
PFE Sentiment 76%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 6.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.2%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Bullish
Bullish news 60%
Bearish news 40%
Bearish news 40%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.71%
12-Months-Change
Fundamentals
Return on Equity
-0.30%
Trailing 12-Months
Asset Growth
13.02%
Trailing 12-Months
Company Description
Pfizer
Pfizer Inc. develops, manufactures and sells healthcare products, including innovative medicines and vaccines. Its key focus areas include oncology, inflammation & immunology, rare disease, vaccines and internal medicine. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
---
PFE Company Deck
---
PFE Earnings Call
Q1 2024
0:00 / 0:00
---
PFE Revenue Breakdown
52.29% Primary Care
25.59% Specialty Care
19.88% Oncology
2.24% BUSINESS INNOVATION
---
PFE Stock 12 Month Forecast
Average Price Target
$31.36
▲(9.50% Upside)
Technical Analysis
Best Analysts Covering PFE
1 Year
1 Year Success Rate
26/34 ratings generated profit
1 Year Average Return
+5.64%
initiated a buy rating 3 months ago
Copying Vamil Divan's trades and holding each position for 1 Year would result in 76.47% of your transactions generating a profit, with an average return of +5.64% per trade.
---